|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-15
|
$1,428,925
|
$171,471
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$749
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$31,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Vorinostat for GVHD prevention in unrelated donor myeloblative conditioning BMT
|
1R21CA198776-01
|
$202,275
|
$202,275
|
CHOI, SUNG
|
UNIVERSITY OF MICHIGAN
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-02
|
$323,700
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
$1,985
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
$60,976
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$263,739
|
$105,496
|
Fowler, Daniel
|
CCR (NCI)
|
|
Transplant Outcomes in Aplastic Anemia
|
ZIA CP010190 - 10508
|
$86,340
|
$86,340
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
Transplant Models
|
ZIA BC 010957
|
$912,450
|
$912,450
|
Gress, Ronald
|
CCR (NCI)
|
|
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
|
5R01CA168814-03
|
$325,553
|
$325,553
|
PACZESNY, SOPHIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
2T32CA009515-31
|
$563,174
|
$563,174
|
PRESS, OLIVER
|
UNIVERSITY OF WASHINGTON
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-27
|
$2,206,479
|
$264,777
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
3P50CA083639-15S1
|
$901,656
|
$54,099
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
1P30CA196521-01
|
$1,695,000
|
$84,750
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
|
1F31CA196231-01
|
$29,640
|
$14,820
|
LIGGETT, LUTHER
|
UNIVERSITY OF COLORADO DENVER
|
|
The Genetics of Post-Transplant Relapse in Myeloid Malignancy
|
5R01CA175008-03
|
$365,200
|
$365,200
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
ZIA SC 010288
|
$527,479
|
$263,739
|
Fowler, Daniel
|
CCR (NCI)
|
|
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
|
5R01CA166794-04
|
$309,342
|
$309,342
|
SERODY, JONATHAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
5K08CA169485-03
|
$171,372
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
1R01CA184728-01A1
|
$401,456
|
$401,456
|
CAO, XUEFANG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
1R01CA193350-01
|
$356,850
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-07
|
$560,424
|
$280,212
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-05
|
$317,475
|
$317,475
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation
|
1K01CA188151-01A1
|
$169,020
|
$169,020
|
OROZCO, JOHNNIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
T cell Development and Regeneration
|
ZIA BC 011633
|
$1,015,742
|
$1,015,742
|
Bhandoola, Avinash
|
CCR (NCI)
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$371,630
|
$278,722
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-02
|
$496,292
|
$496,292
|
ZAIA, JOHN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Stanford University Cancer Center
|
3P30CA124435-08S3
|
$2,249,153
|
$67,475
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-38S1
|
$16,670
|
$333
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-38S2
|
$31,250
|
$625
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-38S3
|
$131,625
|
$2,633
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-38S4
|
$118,659
|
$2,373
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-38S5
|
$150,000
|
$3,000
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
5P30CA016056-38
|
$3,940,043
|
$78,801
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Role of noncoding RNA in Regulating GVHD
|
5R01CA173878-03
|
$322,663
|
$322,663
|
REDDY, PAVAN
|
UNIVERSITY OF MICHIGAN
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-02
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S1
|
$31,250
|
$1,563
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S2
|
$125,000
|
$6,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S3
|
$185,800
|
$9,290
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-52
|
$6,995,267
|
$349,763
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
|
5R01CA183560-03
|
$500,000
|
$500,000
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
|
Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease
|
5R00CA154608-05
|
$249,000
|
$249,000
|
TURTLE, CAMERON
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Programming T Cell Fates for Therapeutic Use
|
ZIA BC 011480
|
$708,828
|
$177,207
|
Gattinoni, Luca
|
CCR (NCI)
|
|
Prevention of bone loss after pediatric hematopoietic cell transplantation
|
5R01CA181024-02
|
$474,096
|
$474,096
|
PETRYK, ANNA
|
UNIVERSITY OF MINNESOTA
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$337,445
|
$337,445
|
Hakim, Frances
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$261,157
|
$261,157
|
Aplan, Peter
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$258,235
|
$154,941
|
Kleiner, David
|
CCR (NCI)
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$501,835
|
$75,275
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-37
|
$259,426
|
$103,770
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Bone Marrow Transplantation for this search: $43,668,333
|